Clinical Trial

Compliant Analysis of Patient Samples and Data

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-04-27; most recent amendment 2026-07-17.
Status change: Recruiting → Enrolling by Invitation 2026-07-17
Trial Details
NCT Number NCT04364503
Lead Sponsor Sequenom, Inc.
Collaborators: Laboratory Corporation of America
Conditions Pregnancy Related, Cancer, Infectious Disease
Enrollment 2,000 participants
Start Date 2018-03-17
Primary Completion 2030-03-17 (estimated)
Study Completion 2030-08-15 (estimated)
Updated on ClinicalTrials.gov 2026-07-21